2-Methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells

Rajendra Bhati, Yesim Gökmen-Polar, George W. Sledge, Cheng Fan, Harikrishna Nakshatri, David Ketelsen, Christoph H. Borchers, Michael J. Dial, Cam Patterson, Nancy Klauber-DeMore

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

2-Methoxyestradiol (2ME2), an estradiol metabolite with antiproliferative and antiangiogenic activities, is in phase I/ II clinical trials for breast cancer. 2ME2 inhibits microtubule polymerization and causes cells to arrest in G2-M. The purpose of this study was to further elucidate the molecular mechanism of 2ME2. MDA-MB-435 breast cancer cells were treated with 2ME2 (2 μmol/L) or vehicle alone. RNA was extracted and genomic profiling was done using 22k Agilent microarrays. Expression Analysis Systematic Explorer was used to determine enrichment of Gene Ontology categories. Protein isolates were subjected to Western blot analysis. Protein synthesis was measured with a [35S]methionine pulse assay. An MDA-MB-435 cell line with two β-tubulin mutations (2ME2R) was used to determine whether novel mechanisms were tubulin-dependent. Gene Ontology categories enriched include genes that regulate the mitotic spindle assembly checkpoint, apoptosis, and the cytosolic ribosome. The target of the mitotic spindle assembly checkpoint is the anaphase-promoting complex (APC). APC inhibition was confirmed by measuring protein levels of its targets securin and cyclin B1, which were increased in 2ME2-treated cells. Because gene expression in the cytosolic ribosome category was decreased, we evaluated whether 2ME2 decreases protein translation. This was confirmed with a pulse assay, which showed decreased isotope incorporation in 2ME2-treated cells, which was maintained in the tubulin-resistant 2ME2R cells. APC inhibition was not maintained in 2ME2R cells. 2ME2 induces tubulin-dependent cell cycle arrest through regulation of genes involved in the mitotic spindle assembly checkpoint, which results in inhibition of the APC and tubulin-independent inhibition of protein translation.

Original languageEnglish (US)
Pages (from-to)702-708
Number of pages7
JournalCancer Research
Volume67
Issue number2
DOIs
StatePublished - Jan 15 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of '2-Methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells'. Together they form a unique fingerprint.

  • Cite this

    Bhati, R., Gökmen-Polar, Y., Sledge, G. W., Fan, C., Nakshatri, H., Ketelsen, D., Borchers, C. H., Dial, M. J., Patterson, C., & Klauber-DeMore, N. (2007). 2-Methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells. Cancer Research, 67(2), 702-708. https://doi.org/10.1158/0008-5472.CAN-06-3406